Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
ABVX
ABVX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ABVX News
Reasons Behind Abivax's 1000% Stock Surge
Feb 27 2026
Fool
Abivax Presents New Findings on Obefazimod at ECCO Congress
Feb 21 2026
NASDAQ.COM
Abivax Presents Obefazimod's First Evidence of Anti-Fibrotic Activity
Feb 21 2026
Newsfilter
Eli Lilly's Decade of Market Dominance
Feb 11 2026
Fool
Eli Lilly Sets High Bar, Competitors Follow Suit
Feb 11 2026
NASDAQ.COM
Investment Comparison: AbbVie vs. Abivax
Jan 30 2026
Fool
Market Competition Analysis: AbbVie vs. Abivax
Jan 30 2026
NASDAQ.COM
Eli Lilly Denies Acquisition Talks with Abivax, CEO Reaffirms No Negotiations
Jan 20 2026
seekingalpha
Abivax (ABVX) Acquisition Potential Could Boost Shares by 72%
Jan 19 2026
NASDAQ.COM
Abivax Shares Surge 1,740%, Eli Lilly May Bid €15 Billion for Acquisition
Jan 19 2026
Fool
Micron Technology (MU) to Acquire Taiwanese Chip Fab for $1.8B
Jan 17 2026
seekingalpha
Nvidia and Eli Lilly Invest $1 Billion in AI Drug Development Lab
Jan 13 2026
Benzinga
Planet Labs PBC Secures Nine-Figure Deal with Swedish Armed Forces, Shares Surge 7%
Jan 12 2026
Benzinga
Eli Lilly Shows Interest in Abivax, a French Biotech Stock That Soared 1,700% in 2025
Jan 12 2026
Barron's
Abivax (ABVX) ADRs Surge 23% on Eli Lilly's €15 Billion Acquisition Interest
Jan 12 2026
seekingalpha
Eli Lilly Plans €15 Billion Acquisition of Abivax
Jan 12 2026
stocktwits
Show More News
